Drug transfer during intimate moments can produce an adverse analytical finding during a doping control: A case report with ligandrol
Journal of Analytical Toxicology · 2025
DOI: 10.1093/jat/bkaf041 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Analytical Toxicology, 2025. Verfasst von Pascal Kintz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institut de médecine légale, 11 rue Humann, Strasbourg, 67000, France. Hauptthemen laut MEDLINE: Doping in Sports, Substance Abuse Detection, Anabolic Agents, Performance-Enhancing Substances. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Selective androgen receptor modulators (SARMs) are a new class of substances that have similar properties to anabolic steroid agents, but with marked reduced androgenic properties. As SARMs have the potential to be misused for performance enhancement in sport due to their anabolic properties as well as their ability to stimulate androgen receptors in the muscle and the bone, they have been prohibited at-all-times by the World Anti-Doping Agency (WADA) since 2008 under section S1.2 of the List. Ligandrol is one of the more popular SARMs. A WADA-accredited laboratory identified bishydroxy-ligandrol in the urine of a female athlete, the major ligandrol metabolite at approximately 90 pg/mL (specimen A) and 200 pg/mL (specimen B). The athlete challenged this anti-doping rule violation and requested a hair test to document possible incidental exposure. About 7 weeks after urine collection, a hair specimen (brown in color and > 20 cm in length) was collected and segmented in 6 × 1 cm segments. Ligandrol was tested by liquid chromatography–tandem mass spectrometry after alkaline incubation and extraction. With a limit of quantitation at 1 pg/mg, no ligandrol was identified. It appears that the athlete was unaware her husband was taking the substance, which was confirmed by his hair test (ligandrol at 7 and 8 pg/mg in 2 × 2.5 cm segments). The Court of Arbitration for Sports accepted the athlete’s explanation that she had been exposed to ligandrol through the exchange of bodily fluids with her husband and lifted her provisional ban. This case demonstrates that drug transfer between two subjects is possible during intimate moments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut de médecine légale, 11 rue Humann, Strasbourg, 67000, France.
- X-Pertise Consulting, 42 rue Principale, Mittelhausbergen, 67206, France.
ORCID-Profile: Pascal Kintz
Zitieren
APA
Kintz, P., & Gheddar, L. (2025). Drug transfer during intimate moments can produce an adverse analytical finding during a doping control: A case report with ligandrol. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkaf041
Vancouver
Kintz P, Gheddar L. Drug transfer during intimate moments can produce an adverse analytical finding during a doping control: A case report with ligandrol. Journal of Analytical Toxicology. 2025. doi:10.1093/jat/bkaf041
BibTeX
@article{Kintz2025,
author = {Kintz, Pascal and Gheddar, Laurie},
title = {Drug transfer during intimate moments can produce an adverse analytical finding during a doping control: A case report with ligandrol},
journal = {Journal of Analytical Toxicology},
year = {2025},
doi = {10.1093/jat/bkaf041}
}
EUVIMED